Abbott said it plans to ship about 30 million tests this month and will be able to ship 60 million tests in June.
The antibody test is Abbott’s fourth COVID-19 test to receive emergency authorization from the FDA and can determine if someone has had COVID-19 and recovered from it.
Abbott said the new test is more efficient and smaller, so it takes up less space in labs.
The test can exclude false positives 99.6 percent of the time and false negatives 100 percent of the time, Abbott said.
Read the full news release here.
More articles on supply chain:
FDA allowed imports of faulty face masks for weeks, NYT finds
Coronavirus testing insufficient to resume elective surgeries, poll of hospitals says
FDA requires devicemakers to report supply issues during pandemic
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
